Literature DB >> 31545372

Global Risk and Elimination of Yellow Fever Epidemics.

Martial L Ndeffo-Mbah1,2, Abhishek Pandey3.   

Abstract

BACKGROUND: Yellow fever (YF) is a vector-borne viral hemorrhagic disease endemic in Africa and Latin America. In 2016, the World Health Organization (WHO) developed the Eliminate YF Epidemics strategy aiming at eliminating YF epidemics by 2026.
METHODS: We developed a spatiotemporal model of YF, accounting for the impact of temperature, vector distribution, and socioeconomic factors on disease transmission. We validated our model against previous estimates of YF basic reproductive number (R0). We used the model to estimate global risk of YF outbreaks and vaccination efforts needed to achieve elimination of YF epidemics.
RESULTS: We showed that the global risk of YF outbreaks is highly heterogeneous. High-risk transmission areas (R0 > 6) are mainly found in West Africa and the Equatorial region of Latin America. We showed that vaccination coverage needed to eliminate YF epidemics in an endemic country varies substantially between districts. In many endemic countries, a 90% vaccination coverage is needed to achieve elimination. However, in some high-risk districts in Africa, a 95% coverage may be required.
CONCLUSIONS: Global elimination of YF epidemics requires higher population-level immunity than the 80% coverage recommended by the WHO. Optimal YF vaccination strategy should be tailored to the risk profile of each endemic country.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  basic reproductive number; global epidemics elimination; threshold vaccination coverage; yellow fever

Year:  2020        PMID: 31545372     DOI: 10.1093/infdis/jiz375

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.

Authors:  Amanda Makha Bifani; Eugenia Z Ong; Ruklanthi de Alwis
Journal:  Curr Treat Options Infect Dis       Date:  2020-07-10

2.  Yellow fever in Asia-a risk analysis.

Authors:  Bethan Cracknell Daniels; Katy Gaythorpe; Natsuko Imai; Ilaria Dorigatti
Journal:  J Travel Med       Date:  2021-04-14       Impact factor: 8.490

3.  Re-emergence of yellow fever in the neotropics - quo vadis?

Authors:  Livia Sacchetto; Betania P Drumond; Barbara A Han; Mauricio L Nogueira; Nikos Vasilakis
Journal:  Emerg Top Life Sci       Date:  2020-12-11

4.  High Rate of Non-Human Feeding by Aedes aegypti Reduces Zika Virus Transmission in South Texas.

Authors:  Mark F Olson; Martial L Ndeffo-Mbah; Jose G Juarez; Selene Garcia-Luna; Estelle Martin; Monica K Borucki; Matthias Frank; José Guillermo Estrada-Franco; Mario A Rodríguez-Pérez; Nadia A Fernández-Santos; Gloria de Jesús Molina-Gamboa; Santos Daniel Carmona Aguirre; Bernardita de Lourdes Reyes-Berrones; Luis Javier Cortés-De la Cruz; Alejandro García-Barrientos; Raúl E Huidobro-Guevara; Regina M Brussolo-Ceballos; Josue Ramirez; Aaron Salazar; Luis F Chaves; Ismael E Badillo-Vargas; Gabriel L Hamer
Journal:  Viruses       Date:  2020-04-17       Impact factor: 5.818

Review 5.  Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.

Authors:  Amanda Makha Bifani; Eugenia Z Ong; Ruklanthi de Alwis
Journal:  Curr Treat Options Infect Dis       Date:  2020-11-06

6.  Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.

Authors:  Jose Mateus; Alba Grifoni; Hannah Voic; Michael A Angelo; Elizabeth Phillips; Simon Mallal; John Sidney; Alessandro Sette; Daniela Weiskopf
Journal:  Viruses       Date:  2020-11-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.